Prot# D9770C00011: A 4-wk, Randomised, Double-Blind, Multicenter, Dose-Finding Phase IIb Study w/AZD0865 25,50,75mg & Esomeprazole 20mg, Given Orally 1x Daily for the Treatment of GERD w/out Erosive Esophagitis According to the LA Classification in Adult

Project: Research project

Project Details

Effective start/end date10/13/044/11/07


  • ICON Clinical Research, LLC (D9770C00011)
  • AstraZeneca LP (D9770C00011)